Literature DB >> 2684554

Recovery of alertness after CPAP in apnea.

J Lamphere1, T Roehrs, R Wittig, F Zorick, W A Conway, T Roth.   

Abstract

Excessive daytime sleepiness is the most common symptom in OSAS. Administering CPAP improves breathing during sleep. We evaluated the time course of the recovery of alertness following CPAP therapy in OSAS patients. Thirty-nine patients with OSAS were treated with CPAP and evaluated after one, 14, or 42 nights of treatment, 13 patients being randomly assigned to each group. All received a diagnostic polysomnogram and MSLT before treatment. The three groups had similar baseline values for nocturnal respiratory disturbance, oxygenation during sleep, fragmentation of sleep, and level of EDS. CPAP treatment was associated with a significant improvement in sleep-related respiration, oxygenation, and sleep fragmentation. The EDS showed significant improvement after one night, and further significant improvement after 14 nights, but no further significant improvement after 42 nights. The differential rate of improvement in nocturnal parameters compared with that of primary complaint of EDS suggests that OSAS patients experience a chronic functional sleep loss. As with sleep deprivation, recovery of alertness in OSAS requires several nights of normal sleep.

Entities:  

Mesh:

Year:  1989        PMID: 2684554     DOI: 10.1378/chest.96.6.1364

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  24 in total

1.  Time course of changes in driving simulator performance with and without treatment in patients with sleep apnoea hypopnoea syndrome.

Authors:  P M Turkington; M Sircar; D Saralaya; M W Elliott
Journal:  Thorax       Date:  2004-01       Impact factor: 9.139

2.  Effects of continuous positive airway pressure on upper airway inspiratory dynamics in awake patients with sleep-disordered breathing.

Authors:  E Vérin; T Similowski; F Sériès
Journal:  J Physiol       Date:  2003-01-01       Impact factor: 5.182

Review 3.  Sleep. 4: Sleepiness, cognitive function, and quality of life in obstructive sleep apnoea/hypopnoea syndrome.

Authors:  H M Engleman; N J Douglas
Journal:  Thorax       Date:  2004-07       Impact factor: 9.139

Review 4.  Sleep.7: positive airway pressure therapy for obstructive sleep apnoea/hypopnoea syndrome.

Authors:  P Gordon; M H Sanders
Journal:  Thorax       Date:  2005-01       Impact factor: 9.139

5.  Driving simulator performance remains impaired in patients with severe OSA after CPAP treatment.

Authors:  Andrew Vakulin; Stuart D Baulk; Peter G Catcheside; Nick A Antic; Cameron J van den Heuvel; Jillian Dorrian; R Doug McEvoy
Journal:  J Clin Sleep Med       Date:  2011-06-15       Impact factor: 4.062

6.  Vitamin B12 Deficiency: A Rare Cause of Excessive Daytime Sleepiness.

Authors:  Imran Khawaja; Kevin Yingling; Hazim Bukamur; Waiel Abusnina
Journal:  J Clin Sleep Med       Date:  2019-09-15       Impact factor: 4.062

7.  Randomised controlled crossover trial of humidified continuous positive airway pressure in mild obstructive sleep apnoea.

Authors:  N S Marshall; A M Neill; A J Campbell; D S Sheppard
Journal:  Thorax       Date:  2005-05       Impact factor: 9.139

8.  Sleep remains disturbed in patients with obstructive sleep apnea treated with positive airway pressure: a three-month cohort study using continuous actigraphy.

Authors:  Jon Tippin; Nazan Aksan; Jeffrey Dawson; Steven W Anderson; Matthew Rizzo
Journal:  Sleep Med       Date:  2016-08-16       Impact factor: 3.492

9.  Daytime sleepiness, cognitive performance and mood after continuous positive airway pressure for the sleep apnoea/hypopnoea syndrome.

Authors:  H M Engleman; K E Cheshire; I J Deary; N J Douglas
Journal:  Thorax       Date:  1993-09       Impact factor: 9.139

10.  Continuous positive airway pressure deepens sleep in patients with Alzheimer's disease and obstructive sleep apnea.

Authors:  Jana R Cooke; Sonia Ancoli-Israel; Lianqi Liu; Jose S Loredo; Loki Natarajan; Barton S Palmer; Feng He; Jody Corey-Bloom
Journal:  Sleep Med       Date:  2009-08-20       Impact factor: 3.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.